You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HCV treatment naive

Showing 1 - 25 of 2,725
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis C, Cirrhosis Trial (Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir)

Not yet recruiting
  • Hepatitis C
  • Cirrhosis
  • (no location specified)
Jul 20, 2022

Hepatitis C, Chronic Trial in Taiwan (P1101 + Ribavirin)

Recruiting
  • Hepatitis C, Chronic
  • P1101 + Ribavirin
  • Chiayi City, Taiwan
  • +7 more
Jun 30, 2022

Zepatier in Patients With Substance Use

Active, not recruiting
  • Hepatitis C
  • +3 more
  • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
  • Chicago, Illinois
    University of Illinois at Chicago
Jun 28, 2022

Hepatitis C Trial in Puerto Rico, United States (ITX 5061, Placebo ITX 5061)

Completed
  • Hepatitis C
  • ITX 5061
  • Placebo ITX 5061
  • Birmingham, Alabama
  • +9 more
Oct 28, 2021

Hepatitis C Trial in Darlinghurst, Sydney, Adelaide (Sofosbuvir 400mg [Sovaldi], Glecaprevir/pibrentasvir (300mg/120mg))

Recruiting
  • Hepatitis C
  • Sofosbuvir 400mg [Sovaldi]
  • Glecaprevir/pibrentasvir (300mg/120mg)
  • Darlinghurst, New South Wales, Australia
  • +2 more
Mar 28, 2022

Oral Glecaprevir/Pibrentasvir Tablet In Pediatric And Adult

Completed
  • Hepatitis C Virus (HCV)
    • Chelyabinsk, Russian Federation
    • +5 more
    Jun 8, 2022

    Chronic Hepatitis C, Chronic Hepatitis B Trial in Beijing (Tenofovir Alafenamide 25 MG, Sofosbuvir / Velpatasvir)

    Recruiting
    • Chronic Hepatitis C
    • Chronic Hepatitis B
    • Tenofovir Alafenamide 25 MG
    • Sofosbuvir / Velpatasvir
    • Beijing, Beijing, China
      Peking University First Hospital
    Aug 2, 2021

    Hepatitis C Trial (clemizole HCl)

    Completed
    • Hepatitis C
    • clemizole hydrochloride
    • (no location specified)
    Apr 13, 2021

    Hepatitis C Infection, Hepatitis C Virus Trial (ombitasvir/paritaprevir/ritonavir, dasabuvir)

    Completed
    Has Results
    • Hepatitis C Infection
    • Hepatitis C Virus
    • (no location specified)
    Jul 28, 2021

    Hepatitis C, Chronic Trial in Taiwan (PEGASYS 180 µg Q1W, P1101 180 µg Q1W, 48 doses, P1101 270µg Q1W, 48 doses)

    Completed
    • Hepatitis C, Chronic
    • PEGASYS 180 µg Q1W
    • +3 more
    • Changhua, Taiwan
    • +12 more
    Oct 7, 2021

    Chronic Hepatitis C Virus Infection Trial in China, Korea, Republic of, Taiwan (P1101 + Ribavirin, PEG-Intron + Ribavirin)

    Completed
    • Chronic Hepatitis C Virus Infection
    • P1101 + Ribavirin
    • PEG-Intron + Ribavirin
    • Beijing, China
    • +38 more
    Jan 14, 2022

    Hepatitis C, HCV Trial in San Antonio (TD-6450, Placebo)

    Completed
    • Hepatitis C
    • HCV
    • San Antonio, Texas
      Texas Liver Institute
    Jan 15, 2021

    Hepatitis C Virus Trial (ABT-450/r/ABT-267, Ribavirin)

    Completed
    Has Results
    • Hepatitis C Virus
    • (no location specified)
    Jul 28, 2021

    Chronic Hepatics C Virus (HCV) Genotype 1, Non-Cirrhotic, Cirrhosis Trial in Beijing (TG-2349, DAG181, Ribavirin)

    Completed
    • Chronic Hepatics C Virus (HCV) Genotype 1
    • +3 more
    • Beijing, China
      Beijing Tsinghua Changgung Hospital
    Feb 2, 2021

    HIV Infection, Hepatitis C Infection Trial in Puerto Rico, United States (Nitazoxanide (NTZ), Pegylated interferon alfa-2a

    Completed
    Has Results
    • HIV Infection
    • Hepatitis C Infection
    • Nitazoxanide (NTZ)
    • +2 more
    • Birmingham, Alabama
    • +17 more
    Nov 2, 2021

    Hepatitis C, Chronic, HIV Infection Trial in Hai Phong, Ho Chi Minh City (Raltegravir, Efavirenz)

    Completed
    Has Results
    • Hepatitis C, Chronic
    • HIV Infection
    • Hai Phong, Vietnam
    • +1 more
    Jul 21, 2021

    Chronic HCV Infection Trial in Clermont-Ferrand (Elbasvir/Grazoprevir Fixed Dose Combination)

    Completed
    Has Results
    • Chronic HCV Infection
    • Elbasvir/Grazoprevir Fixed Dose Combination
    • Clermont-Ferrand, France
      CHU Clermont-Ferrand
    Sep 9, 2020

    Chronic Hepatics C Virus (HCV) Genotype 1, Non-Cirrhotic, Cirrhosis Trial in Beijing (non-cirrhotic subjects. low TG-2349+ low

    Completed
    • Chronic Hepatics C Virus (HCV) Genotype 1
    • +3 more
    • non-cirrhotic subjects. low TG-2349+ low DAG181+Ribavirin
    • +5 more
    • Beijing, Beijing, China
      Peking University Peoples Hospital
    Feb 16, 2021

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for Ribavirin)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • ABT-450/r/ABT-267, ABT-333
    • +2 more
    • (no location specified)
    Jul 8, 2021

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ribavirin)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • ABT-450/r/ABT-267, ABT-333
    • +2 more
    • (no location specified)
    Jul 8, 2021

    Hepatitis C, Chronic Trial in Riyadh (Elbasvir, Grazoprevir 50-100Mg Oral Tablet)

    Completed
    • Hepatitis C, Chronic
    • Elbasvir, Grazoprevir 50-100Mg Oral Tablet
    • Riyadh, Saudi Arabia
      King Fahad Medical City
    Nov 18, 2020

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • ABT-450/r/ABT-267, ABT-333
    • +4 more
    • (no location specified)
    Jul 8, 2021

    Chronic Hepatitis C Trial (Grazoprevir 100 mg/Elbasvir 50 mg fixed-dose combination tablets)

    Completed
    Has Results
    • Chronic Hepatitis C
    • Grazoprevir 100 mg/Elbasvir 50 mg fixed-dose combination tablets
    • (no location specified)
    Jan 15, 2021

    HCV Trial in Beijing (Ravidasvir, Danoprevir, Ritonavir)

    Completed
    • HCV
    • Beijing, Beijing, China
      Peking University People's hospital
    Jul 25, 2020

    Hepatitis C Virus Infection, Response to Therapy of Trial in Cairo (Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER])

    Withdrawn
    • Hepatitis C Virus Infection, Response to Therapy of
    • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
    • Cairo, Almanial, Egypt
      Kasr Alainy Hospital
    Apr 16, 2020